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Eukaryotic translation elongation factor 3 (eEF3) is a fungal-
specific ATPase proposed to catalyze the release of deacylated-
tRNA from the ribosomal E-site. In addition, it has been shown
to interact with the aminoacyl-tRNA binding GTPase elonga-
tion factor 1A (eEF1A), perhaps linking the E and A sites.
Domain mapping demonstrates that amino acids 775–980 con-
tain the eEF1A binding sites. Domain III of eEF1A, which is also
involved in actin-related functions, is the site of eEF3 binding.
The binding of eEF3 to eEF1A is enhanced by ADP, indicating
the interaction is favored post-ATP hydrolysis but is not
dependent on the eEF1A-bound nucleotide. A temperature-
sensitive P915L mutant in the eEF1A binding site of eEF3 has
reduced ATPase activity and affinity for eEF1A. These results
support the model that upon ATP hydrolysis, eEF3 interacts
with eEF1A to help catalyze the delivery of aminoacyl-tRNA at
theA-site of the ribosome.Thedynamics ofwhen eEF3 interacts
with eEF1Amay be part of the signal for transition of the post to
pre-translocational ribosomal state in yeast.
The protein synthetic machinery is characterized by the
interplay of different soluble factors in conjunction with ribo-
somes to translate the mRNA into the correct sequence of
amino acids. The three phases of translation, initiation, elonga-
tion, and termination, are driven by factors that are highly con-
served between yeast and metazoans (1). However, a major dif-
ference in elongation is the indispensability of eukaryotic
elongation factor 3 (eEF3)3 with yeast ribosomes (2, 3). eEF3
catalyzes an essential step in each elongation cycle by virtue of
its ATPase activity. It has been proposed to act as an Exit-site
(E-site) factor, facilitating the release of deacylated-tRNA and
simultaneously impacting on the delivery of aminoacyl-tRNA
(aa-tRNA) at the aminoacyl site (A-site) (4). Metazoan ribo-
somes have been reported to possess a compensatory intrinsic
ATPase activity, although they differ kinetically from the fungal
eEF3 (5). Escherichia coli, on the other hand, expresses the 911
amino acid RbbA protein that exhibits ATPase activity and is
tightly associated with ribosomes (6, 7). Both pathogenic and
non-pathogenic fungi have been reported to contain eEF3
(8–10). In Saccharomyces cerevisiae, eEF3 is encoded by a sin-
gle copy essential YEF3 gene. A paralog of the YEF3 gene, des-
ignatedHEF3 orYEF3B, encodes an 84% identical protein but is
not expressed during vegetative growth (11). However, expres-
sion of the HEF3 coding sequence under the YEF3 promoter
produces a protein that has similar ATPase activity and ribo-
some binding properties to YEF3-encoded eEF3.
eEF3 is a class 1 member of the ATP binding cassette (ABC)
family of proteins. eEF3 possesses distinct motifs including the
HEAT repeats on the N terminus, two nucleotide binding
domains with tandemly arranged bipartite (ABC) cassettes in
the middle, a conserved insertion in the intervening region of
the Walker A and B motifs of ABC2, and a highly basic C ter-
minus. HEAT (Huntington elongation factor 3, A subunit of
protein phosphatase 2A and TOR1) repeats correspond to a
tandem-helical structure that appears to serve as flexible scaf-
folding on which other proteins can assemble. Amino acids
98–388 within the eEF3 N-terminal HEAT domain have also
been shown to interact with the 18 S rRNA (12). Within the
Walker A and Bmotifs, the nucleotide binding stretch of seven
amino acids in ABC1 and -2 are 100% conserved among the
ATP-binding proteins (13). The Walker C motif is the con-
served LSGGQ sequence, the presence of which distinguishes
the ABC proteins from other ATPases (14). Alterations of the
conserved glycine and lysine residues within theWalker A of
either ABC1 or -2 abolish the ATP hydrolytic activity of eEF3
in vitro and are lethal for growth in vivo (15). Interestingly, a
temperature-sensitive (Ts) F650S point mutant in the
intervening region of the two ABC cassettes also affects the
catalytic ATPase activity of the protein, indicating that the
linker region affects either ATP binding or its hydrolysis
(16). Crystal structures of the E. coli transporter system ABC
proteins HisP (17) andMalK (18) as well as the human Rad50
ATPase (19) and cystic fibrosis transmembrane conductance
regulator (20) demonstrate that all possess two associated
monomers. Each monomer harbors a single ABC cassette
and forms a homodimer in the presence of ATP to carry out
hydrolysis, although there is variation in the manner by
which each nucleotide binding domains from the two mono-
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mers collaborate to bind ATP molecules (21). The lysine-
rich C terminus of eEF3 (amino acids 980–1044) has previ-
ously been implicated as required for binding to the
ribosome (22, 23).
During translation elongation, delivery of aa-tRNA to the
A-site by eEF1A and the translocation of the ribosome by
eukaryotic elongation factor 2 (eEF2) require GTP hydrolysis
(1). The unique role of eEF3may be part of the transition of the
post-translocational to the pre-translocational state via its ATP
hydrolytic activity in yeast. The allosteric three-site model sug-
gests that only two tRNAs can occupy the ribosome at one time,
and thus, the exit of deacylated-tRNA is a prerequisite or coreq-
uisite for the delivery of aa-tRNA to the A-site (24). eEF3 has
been proposed to aid this removal and help promote the deliv-
ery of only cognate aa-tRNA by eEF1A to the A-site (4). It
remains unclear how andwhen eEF3 utilizes its ATP hydrolytic
activity to carry out these functions.
To address this question the present study analyzed the
regions involved in, and the nucleotide-bound state that favors
eEF3 binding to eEF1A. Our results point toward an enhanced
eEF3 and eEF1A association in the presence of ADP, suggesting
that ATP hydrolysis likely precedes eEF3 binding to eEF1A.
The eEF1A binding region of eEF3 has been mapped to 2
regions near the C terminus. A genetic screen conducted in the
current study resulted in a pointmutation in one of the regions.
A strain expressing the P915L eEF3 exhibits a temperature-
sensitive (Ts) growth defect and reduction in total translation.
Additionally, the protein has negligible intrinsic and ribosome-
stimulated ATPase activity and shows reduced affinity for
eEF1A.
EXPERIMENTAL PROCEDURES
Yeast and Bacterial Strains, Growth, Drug Sensitivity, and
Translation Assays—S. cerevisiae strains and their genotypes
are listed in Table 1. E. coliDH5was used for plasmid prep-
aration. Procedures for cell growth and genetic manipula-
tions were according to standard protocols (27). Yeast cells
were grown in either YEPD (1% Bacto-yeast extract, 2% pep-
tone, 2% dextrose) or in defined synthetic complete medium
(C or C) supplemented with 2% dextrose as the carbon
source unless noted. Yeast were transformed by the lithium
acetate method (28). Temperature sensitivity was assayed by
growing strains to anA600 of 1.0. Serial 10-fold dilutions (5l
each) were spotted on appropriate medium followed by
incubation at 13, 24, 30, and 37 °C for 3–7 days. Phenotypic
suppression of a non-programmed 1 frameshift allele
(met2-1 and his4-713) was determined by spotting 10 l of
the same dilutions onto complete medium lacking methio-
nine or histidine, respectively, and incubating for 5 days at
30 °C. Halo assays for sensitivity to cycloheximide, paromo-
mycin, and hygromycin B were performed as previously
described (29). Total yeast translation was monitored by in
vivo [35S]methionine incorporation as previously described
at both 30 and 37 °C (30) using the indicated MET2 strains.
Isolation of the P915L eEF3 Mutant by Hydroxylamine
Mutagenesis—Ten g of plasmid DNA (pTKB594) harboring
YEF3 on a CEN TRP1 plasmid was added to 500 l of 1 M
hydroxylamine, pH 7.0. The reaction was incubated at 37 °C for
20 h and stopped by adding 100mMNaCl and 0.1 g/l bovine
serum albumin. DNA was ethanol-precipitated, transformed
intoTKY554, andplated onC-Trp to select for themutated yef3
TRP1plasmid at a density of150–300 cells/plate. Cells able to
lose the wild type YEF3 URA3 plasmid were identified by
growth on 5-fluoroorotic acid-containing media. The resulting
strains expressing the yef3 TRP1 plasmid as the only form were
analyzed for growth at 13, 30, or 37 °C. A colony unable to grow
at 37 °C was recovered from the 30 °C plate, and the plasmid
was extracted, transformed in E. coli, recovered, and retrans-
formed into TKY554. Loss of the wild type YEF3 plasmid was
repeated to confirm the phenotype. The P915L eEF3 mutant
plasmid pTKB753 isolated in this screen was also constructed
with a His6 tag on the N terminus by site-directed mutagenesis
of pTKB602 by the QuikChange method (Stratagene), produc-
ing pTKB777.
Cloning, Expression, and Purification of GST and His6-
tagged eEF3, eEF1A, and Truncations—Full-length eEF3 and
fragments containing amino acids 1–775 (85NT), 100–367
(HEAT), 775–910 (I), 910–1044 (15CT), and 775–1044
(30CT) were PCR-amplified using pTKB594 as the template.
Fragments were cloned into pTKB544 for expression with a
galactose-inducible promoter (GAL1-10) and an N-terminal
GST tag, resulting in plasmids pTKB705, pTKB706,
pTKB707, pTKB708, pTKB709, and pTKB710, respectively.
The plasmids expressing the GST-tagged eEF3 fragments
were transformed in TKY555 and maintained on C-Ura-
Hisgalactose media for protein expression. Yeast cultures
expressing the GSTeEF3 fusions were harvested at an A600 of
1.0–2.0, and total yeast extracts were clarified and loaded on
the GST Trap column (Amersham Biosciences) in buffer A
(20 mM Tris-HCl, pH 8.0, 100 mM KCl, 1 mM DTT, and 0.2
mM PMSF). The protein was eluted with buffer A plus 20 mM
TABLE 1
S. cerevisiae strains used in this study
Strains Genotype Source
TKY554 MAT ura3-52 leu2-3, 112 trp1-7 lys2-1243 met2-1 his4-713 yef3::LEU2 2 pYEF3 URA3 Ref. 16
TKY555 MAT ura3-3 leu2-2 trp1-1 his3-3 pMA210 (GAL4 2 HIS3) This study
TKY597 MAT ura3-52 leu2-3, 112 trp1-7 lys2-1243 met2-1 his4-713 yef3::LEU2 CEN pYEF3 TRP1 This study
TKY616 MAT ura3-52 leu2-3, 112 trp1-1 lys2-20 met2-1 his4-713 tef1::LEU2 tef2 CEN His6 pTEF1 TRP1 This study
TKY676 MAT ura3-52 leu2-3, 112 trp1-7 lys2-1243 met2-1 his4-713 yef3::LEU2 CEN His6 pYEF3 TRP1 This study
TKY702 MAT ura3-52 leu2-3, 112 trp1-7 lys2-1243 met2-1 his4-713 yef3::LEU2 2 His6 pYEF3 TRP1 Ref. 16
TKY800 MAT ura3-52 leu2-3, 112 trp1-7 lys2-1243 met2-1 his4-713 yef3::LEU2 CEN pyef3 TRP1(P915L) This study
TKY805 MAT ura3-52 leu2-3, 112 trp1-7 lys2-1243met2-1 his4-713 yef3::LEU2 2 His6 pyef3 TRP1 (980eEF3) This study
TKY819 MAT ura3-52 leu2-3, 112 trp1-7 lys2-1243 met2-1 his4-713 yef3::LEU2 CEN His6 pyef3 TRP1 (P915L) This study
TKY822 MAT ura3-52 leu2-3, 112 trp1-7 lys2-1243 MET2 his4-713 yef3::LEU2 CEN His6 pYEF3 TRP1 This study
TKY824 MAT ura3-52 leu2-3, 112 trp1-7 lys2-1243 MET2 his4-713 yef3::LEU2 CEN pyef3 TRP1 (P915L) This study
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reduced glutathione (Sigma). The protein peak was dialyzed
into buffer B (20 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, 10%
glycerol, 1 mM DTT, 0.2 mM PMSF, and 100 mM KCl).
To facilitate eEF3 purification from yeast, a His6 tag was
added to the N terminus of S. cerevisiae eEF3 under the con-
trol of its own promoter on a CEN TRP1 plasmid producing
pTKB602 (31). A yeast plasmid expressing His6980 eEF3 was
produced by introduction of a stop codon at amino acid 981
by QuikChange, producing pTKB724 (31). The plasmids
were introduced into S. cerevisiae strain TKY554, and loss of
the wild type eEF3 on a URA3 plasmid was monitored by
growth on 5-fluoroorotic acid, producing TKY702 and
TKY805, respectively.
His6-tagged wild type eEF1A, eEF3, 980eEF3, and P915L
eEF3 proteins were purified from strains TKY616, TKY702,
TKY805, and TKY819, respectively, on a Ni2 Hi Trap chelat-
ing column (Amersham Biosciences). Total yeast extracts were
clarified and loaded on the column in buffer C (50 mM KPO4,
pH 7.6, 300mMKCl, 1mMDTT, and 0.2mMPMSF)with 20mM
imidazole. The protein was eluted with buffer C plus 400 mM
imidazole. The protein peak was dialyzed into buffer B.
BspEI restriction sites were introduced upstream of the ATG
initiation codon and downstream of the TAA stop codon using
the QuikChange protocol in TEF1 on pTKB731 as template,
producing pTKB740. His6-tagged eEF1Awith BspEI restriction
sites upstream and downstream of the open reading frame was
constructed by PCR and cloning into pTKB740, resulting in
plasmid pTKB779. Domain I (amino acids 1–221) was con-
structed by QuikChange mutagenesis of the Lys-222 and Lys-
224 codons toTAAusing pTKB779, producing pTKB852.His6-
tagged domain III (amino acids 333–458) was obtained by
looping out domains I and II using site-directed mutagenesis
protocol of template pTKB779, producing pTKB785. Plasmids
pTKB852 and pTKB785 were used as templates for PCR ampli-
fication of His6-domain I and His6-domain III fragments to
clone into the pET11a vector, resulting in plasmids pTKB863
andpTKB851, respectively.His6-tagged domain II (amino acids
222–316) in pET11a was constructed by QuikChange
mutagenesis of the Glu-316 and Arg-318 codons to TAA and
TGA, respectively, using pTKB864 as the template to produce
pTKB920.
A 1-liter culture of E. coli BL21 with each plasmid was grown
to an A600 of 0.6 in LB with 100 g/ml ampicillin medium.
Protein expression was induced with 1mM isopropyl--D-thio-
galactopyranoside at 37 °C for 3–4 h. Cells were harvested by
centrifugation and lysed by sonication, and the recombinant
protein was purified in accordance with the QIAexpressionist
protocol for His6-tagged proteins under native conditions. Pro-
tein-containing fractions were dialyzed into 20 mM Tris-HCl,
pH7.5, 1mMDTT, 0.1mMEDTA, pH8.0, 100mMKCl, and 20%
glycerol.
ATP Hydrolysis—ATP hydrolysis was performed using puri-
fied proteins as previously described (32). Briefly, the assaymix-
ture contained 24 pM protein, 50 pM yeast ribosomes, and 150
M [-32P]ATP. Hydrolysis was allowed to proceed for 5min at
30 °C, and 32Pi release was determined. ATP hydrolysis levels
were calculated after subtracting the background for buffer
alone.
GST and His6 Pulldowns of eEF1A and eEF3—Yeast extracts
for in vivo binding assays were prepared by glass bead lysis in
TEDG buffer (10 mM Tris-HCl, pH 7.4, 2 mM EDTA, 5 mM
DTT, 50 mM KCl, and 1 mM PMSF) from TKY555 with the
empty plasmid pTKB544, GSTeEF3 (pTKB705), or the GST-
eEF3 fragments (pTKB706, pTKB707, pTKB708, pTKB709,
pTKB710). For GST and Ni2-NTA pulldown assays, 200-l
reactions containing 50 g of total protein (determined by
Bradford reagent; Bio-Rad) and 40l of either 50% glutathione-
Sepharose 4B slurry (Sigma) in KETN 150 buffer (150 mM KCl,
1 mM EDTA, 20 mM Tris-HCl, pH 8.0, 0.5% Nonidet, and 1 mM
PMSF) or Ni2-NTA slurry (Amersham Biosciences, GE
Healthcare) in buffer C were mixed at 4 °C for 1 h. Beads were
washed 3 times with either KETN buffer with 150 or 300 mM
KCl for GST pulldown or buffer C with 100 mM imidazole for
Ni2-NTA pulldown. Samples were resolved by SDS-PAGE,
and were proteins were detected with a polyclonal antibody
to yeast eEF1A and ECL (Amersham Biosciences) and quan-
titated with the ImageQuant program (GE Healthcare).
Ni2-NTA pulldown of purified untagged eEF1A with His6-
tagged eEF3 or untagged eEF3 with His6-tagged eEF1A were
performed with 2 g of eEF3 and 3 g of eEF1A as previously
described (33).
Ribosome Binding Assay—The ribosome binding assay was
performed as described previously (34) with minor modifica-
tions. Fifty-l reactions containing 24 pM purified proteins and
24 pM 80 S ribosomes in binding buffer (20 mM Tris-HCl, pH
7.5, 50 mM ammonium acetate, 10 mMmagnesium acetate, and
2 mM DTT) were incubated for 5 min at room temperature,
layered on top of a 200-l sucrose cushion (10% sucrose in
binding buffer), and centrifuged at 74,000 rpm for 20 min at
4 °C in S80-AT2 (Sorvall) rotor. The pellet (bound fraction) was
resuspended in Laemmli loading buffer and subjected to SDS-
PAGE andWestern blot analysis using the ECLmethod (Amer-
sham Biosciences).
Enzyme-linked Immunosorbent Assays—In vitro binding
was measured by an indirect enzyme-linked immunosorbent
assay. Purified GSTeEF3 (0.25 g) in 50 l of PBST (137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4)/
well was coated overnight at room temperature in a 96-well
ultrahigh binding polystyrene microtiter plate (Thermo-
Labsystem). After blocking with 300 l of 0.1% bovine serum
albumin in PBST for 1 h at room temperature and washing 3
times with 300 l of PBST, 50 l of 5000-fold-diluted affin-
ity-purified polyclonal anti-eEF3 antibody was added to each
well and incubated at room temperature for 2 h. Varying
amounts of eEF1A along with varying amounts of ATP, ADP,
GTP, or GDPwere added to the eEF3 antibody. After washing 3
times with 300 l with PBST, 50 l of 2500-fold-diluted sec-
ondary goat anti-rabbit antibody conjugated with alkaline
phosphatase was added per well (Jackson ImmunoResearch).
Unbound antibody was removed by three washes of 300 l of
PBST followed by the addition of 50 l of 3 mM p-nitrophenyl
phosphate (Sigma) in 50 mM Na2CO3 and 50 M MgCl2/well.
The extent of p-nitrophenyl phosphate hydrolysis represents
the antigen-antibody binding measured by A415.
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RESULTS
eEF3 Interacts with eEF1A through Its C-terminal Region—
Prior studies have demonstrated that eEF3 and eEF1A inter-
act, as monitored by both genetic and physical assays in vivo
and in vitro (16). To map the site of interaction, five fragments
of eEF3 corresponding approximately to natural proteolytic
sites were cloned into a GAL1-10-inducible expression vector
with a GST tag at the N terminus (Fig. 1A). These include full-
length eEF3 (amino acids 1–1044), 85NT, (1–775), HEAT
(100–367), 15CT (910–1044), I (775–910), and 30CT (775–
1044). All the fragments are expressed in yeast although at dif-
ferent levels, asmonitored byWestern blot with anti-GST anti-
body (Fig. 1B). The GST-tagged fusion proteins migrate at 140
(eEF3), 105 (85NT), 57 (HEAT), 42 (15CT), 58 (30CT), and 42
(I) kDa, with 29 kDa contributed by the GST tag. The same gel
is also probed with anti-eEF1A antibody as the internal loading
control.
Because none of the eEF3 fragments can replace wild type
eEF3 in vivo (data not shown), all were co-expressed with an
untagged wild type copy of eEF3 to support growth. A GST
pulldown assay was performed to determine the binding of
eEF3 to eEF1A in total cell extracts. The 15CT, I, and 30CT
GST fusion fragments co-purified
eEF1A at levels similar to or above
that of full-length eEF3. The 85NT,
GST alone, and HEAT fragments
co-purified less eEF1A, although
some background level of binding
was observed (Fig. 1C). The same
experiment was also probed for
co-elution of ribosomes with the
eEF3eEF1A complex. As shown in
Fig. 1C, bottom panel, RPL10e, a
ribosomal protein, is absent in
the bound fractions. The middle
panel, Fig. 1C, shows probing for
phosphoglycerate kinase (PGK1)
as the internal loading control.
Because the fusion truncations are
expressed at different levels in vivo,
the 85NT, 30CT, and 15CT GST-
tagged fragments were purified
from yeast, and GST pulldown
experiments were performed with
purified untagged yeast eEF1A. The
GST-HEAT and GST-I fusion were
not stably expressed at sufficient
levels for purification. GST-15CT
and GST-30CT co-purified with
eEF1A at levels comparable with
wild type GSTeEF3, whereas the
GST-85NT was at background lev-
els (GST, Fig. 1D). The results in Fig.
1, C and D, demonstrate that the
eEF3eEF1A interaction occurs in
the absence of any cellular factors
via the C-terminal region of eEF3.
Dominant growth phenotypes
conferred by the truncations were monitored on C-Ura-
Hisgalactose medium at different temperatures. The 30CT
and 15CT fragments confer a dominant slow growth phenotype
at 13 °C, whereas no effects were seen at 30 or 37 °C (Fig. 1E and
data not shown). Because there appear to be two eEF1Abinding
sites, one within amino acids 775–910 and one within 910–
1044, fragments of eEF3 containing these amino acids may
exhibit a dominant slow growth phenotype due to the forma-
tion of inactive complexes with eEF1A. The I fragment (775–
910) does not show this growth phenotype, indicating the site
from 910 to 1044 may have a larger effect in vivo.
His6980eEF3 Is Functional in Vivo and Retains Binding to
Ribosomes and eEF1A—Prior work proposed that the C-termi-
nal 64 amino acids (980–1044), containing 40% basic residues,
is the primary ribosome binding region of eEF3 (22). Other
work suggests theN-terminal 98–388 amino acids binds to 18 S
rRNA in vitro and inhibit the ribosome-dependent ATPase
activity of eEF3 (12). To determine the function of the basic C
terminus of eEF3, His6-tagged eEF3 1–980 was expressed from
a 2 TRP1 plasmid. This construct was able to function as the
only formof eEF3 (Fig. 2A). Cells expressingHis6980eEF3 as the
only form of eEF3 have a slight slow growth phenotype (Fig.
FIGURE1.C-terminal regionsofeEF3bindeEF1A.A, eEF3 fragments clonedasGST fusionsunder theGAL1-10
promoter in pTKB544. B, plasmids expressing the GST fusion fragments from A were transformed in TKY555
and maintained in C-Ura-Hisgalactose. Strains were grown to mid-log phase at 30 °C, yeast extracts were
prepared, andequal amountsofprotein (5g)were separatedbySDS-PAGEandsubjected toWesternblotting
with an anti-GST monoclonal antibody. The lower panel shows eEF1A as the internal loading control. C, a GST
pulldownassaywasperformedwith theextracts (50g) from the same strains as inB, and theWesternblotwas
developed with an anti-eEF1A antibody (top panel), anti-phosphoglycerate kinase (PGK1) antibody represent-
ing internal loading control (middle panel) and anti-RPL10e antibody to detect co elution ribosomes with the
eEF3eEF1A complex (lower panel). E, extract (10% input); S, supernatant (5%); P, pellet (100%). D, a GST pull-
down assaywith purified yeast eEF1A (100 pM) andGST-tagged eEF3, 30CT, 15CT, and 85NT fragments (20 pM).
E, the yeast strains fromBwere grown tomid-log phase at 30 °C, diluted to equal A600, spotted as 10-fold serial
dilutions, and grown at 13 or 24 °C for 2–7 days.
eEF3 and eEF1A Interaction
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2A). This effect is most noticeable at 13 °C. Western blot anal-
ysis of His6eEF3, wild type eEF3, and His6980eEF3 from strains
TKY702, TKY554, and TKY805 with anti-eEF3 antibody (Fig.
2B) shows that His6980eEF3 protein is expressed at similar lev-
els as full-length-tagged and untagged eEF3. The same gel was
also probed with anti-eEF1A antibody as internal loading con-
trol. Therefore, although His6980eEF3 is stably expressed, its
function in vivo is likely partially compromised.
The role of amino acids 981–1044 in binding eEF1A was
determined by Ni2-NTA pulldown of extracts from strains
expressing His6980eEF3, His6eEF3, or untagged eEF3. Super-
natant and pellet fractions were resolved by SDS-PAGE, and
the Western blot was probed with anti-eEF1A and anti-eEF3
antibodies. eEF1A associates with His6980eEF3 at levels com-
parable with full-lengthHis6eEF3 (Fig. 2C). In the negative con-
trol with untagged eEF3, minimal background eEF1Awas pres-
ent in the pellet. The Ni2-NTA pulldown was also performed
with purified proteins, confirming that eEF1A binds to both
His6eEF3 and His6980eEF3 directly (Fig. 2D). This indicates
that residues 981–1044 are not required for eEF1A binding.
Taken together with the truncation data (Fig. 1, C and D), it
appears one eEF1Abinding site is locatedwithin the 205-amino
acid stretch from 775 to 910 and a second within amino acids
910–980.
To determine whether the C
terminus of eEF3 is dispensable
for ribosome binding, purified
His6eEF3 and His6980eEF3 were
assayed for co-association with
ribosomes through a sucrose cush-
ion (Fig. 2E). The slowest migrating
bands corresponding to the full-
length and 1–980 proteins pellet
with ribosomes. Interestingly, the
same degradation products were
observed for both eEF3 and
980eEF3. All three bands reacted
with the anti-His6 antibody (data
not shown), and because the His tag
was located at the N terminus, this
indicates the N terminus is intact.
Thus, these fragments represent
C-terminal truncations and imply
ribosome binding occurs near the N
terminus. This is consistent with
work showing an N-terminal frag-
ment binds 18 S rRNA (12). The
negative control bovine serum albu-
min stayed in the supernatant both
in the presence and absence of ribo-
somes (data not shown).
ADP Enhances the Association of
eEF3 with eEF1A—Because both
eEF3 and eEF1A bind nucleotides,
an enzyme-linked immunosorbent
assay-based binding assay was
developed to look at the effect of
these molecules on the eEF1A-eEF3
interaction. Subsequent to coating the wells with purified
eEF3, eEF1A was added to compete with an anti-eEF3 anti-
body. Because eEF1A binding competes with antibody bind-
ing, the absorbance value is reduced in the presence of
eEF1A. Concentration-dependent eEF1A binding to eEF3
was observed (Fig. 3A). A 10-fold molar excess of eEF1A to
eEF3 was used for all further assays. A series of controls was
included in this assay to validate these results. These
included demonstrating that the anti-eEF3 antibody does
not show any affinity for eEF1A, the addition of nucleotide
alone in the absence of anti-eEF3 antibody exhibits negligi-
ble absorbance, and the addition of nucleotides alone (in the
absence of competing factor eEF1A) along with anti-eEF3
antibody does not affect absorbance (data not shown).
To ascertain the effect of the nucleotide-bound state on the
binding of the two proteins, ATP, ADP, GTP, or GDP was
added with the anti-eEF3 antibody and eEF1A. Whether GTP
or GDP was incubated with eEF1A and eEF3, the signal
remained constant, and thus, binding was unaffected (Fig. 3B).
On the other hand, there is a concentration-dependent reduc-
tion in signal, and hence, stimulation of eEF1A binding when
ADP was added. This is shown as binding normalized to
absorbance in the presence of nucleotide alone and in the
absence of eEF1A (Fig. 3C). Furthermore, whenATPwas added
FIGURE 2. His6980eEF3 is functional in vivo and retains binding to eEF1A and ribosomes. A, strains con-
taining plasmid-borne untagged eEF3 (2m, TKY554), His6-tagged eEF3 (CEN, TKY676), His6eEF3 (2, TKY702),
and His6980eEF3 (2, TKY805) were grown tomid-log phase at 30 °C, diluted to equal A600, spotted as 10-fold
serial dilutions, and grown at 24 or 13 °C for 2–7 days. B, yeast extracts (2 g) were prepared from strains
expressing His6eEF3 (TKY702), eEF3 (TKY554), and His6980eEF3 (TKY805) and analyzed for the expression of
His6980eEF3 byWestern blottingwith an anti-eEF3 antibody. The lower panel shows equal loading of eEF1A as
internal control. C, in vivo eEF1A binding to His6eEF3 and His6980eEF3 was analyzed by Ni
2-NTA pulldown of
yeast extracts (50g) from strains as in A. S, supernatant (5%) and P, pellet (100%)were subjected to SDS-PAGE
and Western blot with anti-eEF1A and anti-His6 antibodies. D, in vitro binding of purified His6eEF3 and
His6980eEF3 in a 5-foldmolar excess of untagged eEF1Awas assessed by Ni
2-NTA pulldown and analyzed by
SDS-PAGE and Western blot with anti-eEF1A antibody. E, association of eEF3 with purified 80 S ribosomes
through a 10% sucrose cushion is shown for His6980eEF3 and His6eEF3 and analyzed as inDwith an anti-eEF3
antibody. P, pellet (100%); S, supernatant (20%).
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there was a concentration-dependent increase in signal, and
hence, reduction in binding was observed. The experiment was
done multiple times to confirm a reproducible trend.
To confirm the enzyme-linked immunosorbent assay-based
assay, a GST pulldown of purified untagged eEF1A with
GSTeEF3 was performed in the presence of different concen-
trations of nucleotide and analyzed by SDS-PAGE followed by
gel code blue staining. The amount of eEF1A bound to
GSTeEF3 in the pellet increases in the presence of increasing
amounts of ADP (Fig. 3,D and E). Thus, results from two inde-
pendent methods indicate that binding of eEF1A to eEF3 is
likely stimulated after ATP hydrolysis.
Proteins belonging to the ABC superfamily are inter- or
intramolecular dimers, and the presence of two ATPase
domains is required for function (35). To confirm His6eEF3
is a monomer, purified protein was subjected to analysis by
gel filtration chromatography on a Superdex 200 column
(Amersham Biosciences) (Fig. 3F).
His6eEF3 eluted as a single sharp
peak with a retention time of 29.24
min corresponding to a molecular
mass of 140 kDa. The migration
remains unchanged in 1 M KCl, 1
mM ATP, 1 mM ADP, or 50 mM
ethylene glycol (data not shown),
showing that eEF3 exists as a mon-
omer in its purified form.
A P915L Mutation in an eEF1A
Binding Site of eEF3 Alters ATPase
Activity and eEF1A Binding—A
genetic screen for conditional mu-
tants in eEF3 was conducted using
unbiased in vitro mutagenesis of a
YEF3 plasmid. A pool of hydroxy-
lamine-treated plasmids was trans-
formed into yeast, and plasmids able
to replace the wild type YEF3 URA3
plasmidwere determined by growth
on 5-fluoroorotic acid. Approxi-
mately 7000 colonies were screened
for temperature-sensitive growth
yielding a strain expressing a single
eEF3 point mutation, P915L, in the
C-terminal region (Fig. 4A). The
doubling time of the P915L mutant
strain was 5.5 h comparedwith 3.5 h
for the wild type strain. Total pro-
tein synthesis monitored by meas-
uring [35S]methionine in the P915L
strain was 20% less than a wild type
strain at permissive temperatures
and 22% less than wild type when
cells were shifted to 37 °C (Fig. 4B).
To determine the eEF3 defect caus-
ing this effect, theATPase activity of
purified His6P915L eEF3 was deter-
mined. The mutant lacks both
intrinsic and ribosome-stimulated
ATPase activity (Fig. 4C). To assess if this loss of catalytic activ-
ity affects eEF1A binding to the P915L eEF3 mutant, associa-
tion was assessed by Ni2-NTA pulldown assay. His6P915L
eEF3pulls down reduced levels of eEF1Aas comparedwithwild
type His6eEF3 in both cell extracts (Fig. 4D) and with purified
proteins (Fig. 4, E and F). A small amount of eEF1A is nonspe-
cifically pulled down by untagged eEF3 usingNi2-NTA beads.
This implies that binding of eEF3 to eEF1A is sensitive to struc-
tural and functional alterations caused by a point mutation in a
region proposed to bind eEF1A.
eEF1A Binds eEF3 via Domain III—The co-crystal structure
of eEF1A with its guanine nucleotide exchange factor eEF1B
shows the G-protein has three domains. Domain I contains the
GTP binding motifs, and domains I and II contact eEF1B (33,
36). Domain III has been shown to interact with actin and is
responsible for the non-canonical functions of eEF1A in actin
binding and bundling (25) and the slow growth phenotype asso-
FIGURE 3. ADP stimulates eEF1A binding to eEF3. A, microtiter 96-well plates (Falcon) were coated with
purified GSTeEF3 (0.25 g), and an affinity-purified anti-eEF3 antibody was added with or without increasing
amounts of eEF1A. eEF1A (1.25g)was incubated in theGSTeEF3-coatedmicrotiter plate as inA, with different
concentrations of nucleotides, GTP (diamonds) or GDP (squares) in B expressed as A415 or ATP (diamonds), or
ADP (squares) in C expressed as percentage bound normalized to the presence of nucleotide alone in the
absence of eEF1A. D, eEF1A bound to GSTeEF3 after GST pulldown in the presence of varying amounts of ADP
were analyzedby SDS-PAGE and stainedwith gel codeblue (Pierce). S, supernatant (5%); P, pellet (100%). E, the
results of GST pulldown experiments as inDwas analyzedwith the ImageQuant program (GE Healthcare), and
the ratio of pellet to supernatantwas plotted. F, purifiedHis6eEF3was subjected togel filtration analysis by fast
protein liquid chromatography on a Superdex 200 column (Amersham Biosciences). The elution profile of
His6eEF3 was determined by SDS-PAGE and Western blot with an anti-eEF3 antibody.
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ciated with eEF1A overexpression in vivo (26). To identify the
eEF1A region involved in binding to eEF3, purified wild type
His6eEF1A from yeast and His6 fusions of domain I (1–221, 22
kDa,), II (222–332, 11 kDa), or III (333–458, 33 kDa) purified
from E. coli (Fig. 5A) was used to determine GSTeEF3 binding
by Ni2-NTA pulldowns. GSTeEF3 was pulled down only by
wild type His6eEF1A and His6-domain III (Fig. 5B). No
GSTeEF3 binding was seen by either domains I or II.
DISCUSSION
Protein synthesis in yeast relies not only on the availability of
the eEF1AB complex and eEF2 but also another unique fac-
tor, eEF3. The absolute dependence of the pathogenic fungal
translationmachinery on the presence of eEF3 can be exploited
as a fungal-specific drug target (37). To achieve this long-term
goal, our primary aim is to understand the role of eEF3 in pro-
tein synthesis. Previously published work has assigned eEF3
the dual roles of removing the deacylated-tRNA from the
E-site of the ribosome and aiding eEF1A in the delivery of the
correct aa-tRNA to the A-site. eEF3 has been shown to inter-
act physically with both eEF1A and ribosomes. The mystery
of how and when eEF3 collaborates with its interacting part-
ners to carry out its essential steps
in translation elongation is still
not well understood. Recent work
in bacteria confirms the allosteric
link between the A and E sites (38).
This supports the hypothesis that
a general ribosome function is the
release of deacylated tRNA from
the E-site preceding the GTP
hydrolysis required to deposit aa-
tRNA at the A-site. This step likely
involves a conformational change
in the 70 S ribosome. Because bac-
teria lack eEF3, although the ribo-
some-associated ATPase RbbA
has been implicated as a bacterial
counterpart of eEF3 (39), the bind-
ing of the ternary complex of aa-
tRNA-EF-Tu-GTP has been sug-
gested to induce the required
conformational change in the
ribosome to catalyze the release of
deacylated-tRNA from the E-site
(38). In mammals, the ribosome-
associated ATPase activity from
pig liver differs from the yeast
eEF3 ATPase activity in its sensi-
tivity to translation inhibitors and
nucleotide dependence (40).
Previous reports have proposed
two different ribosome binding
regions in eEF3, the 64 amino acids
at the C terminus (22) and the
N-terminal residues 98–388 (12). In
the present study we report that
yeast expressing eEF3 in the absence
of its 64 amino acids at the C terminus are viable, and both the
eEF1A and ribosome binding properties are retained by
His6980eEF3. Thus, theN-terminal region is likely the predom-
inant ribosome binding site.
The family of ABC protein includes membrane-bound fac-
tors, which function in transporting solute molecules against a
concentration gradient. However, the soluble members of this
family, including Gcn20p, RL11 (41), eEF3, and the recently
reported ARB1 (42) in yeast are also implicated in functions
related to protein synthesis, ribosome biogenesis, and transla-
tion elongation. The crystal structure of several members of
the class I ATPases clearly establish the phenomena of
homodimerization of two ABC proteins to sandwich two ATP
molecules utilizing theWalker A and B motifs of the one mon-
omer (43, 44) and Walker C or the conserved LSGGQ motif,
characteristic of only the ABCmembers of the ATPases super-
family, from the other monomer. It has been shown for cystic
fibrosis transmembrane conductance regulator that upon ATP
hydrolysis, the dimerized cassettes come apart, and this motor
motion drives the transport across the membrane (45). Inter-
estingly, the soluble members of the ABC family harbor both
the cassettes in tandem in a single molecule. Our investigation
FIGURE 4. The ATP hydrolysis deficient P915LeEF3 mutant shows reduced affinity for eEF1A. A, strains
containing wild type eEF3 (TKY597) or P915LeEF3 (TKY800) were grown to mid-log phase at 30 °C, diluted to
equal A600, spotted as 10-fold serial dilutions, and grown at 30 or 37 °C for 2–7 days. B, strains expressing
His6P915LeEF3 (TKY824) or His6eEF3 (TKY822) were monitored for total translation by [
35S]methionine incor-
poration after growth to mid-log phase in C-Met and labeled for varying times at both 30 and 37 °C. Total
translation is expressed as cpm/A600 unit.Wt, wild type. C, intrinsic and ribosome (Rbs)-stimulated ATP hydro-
lytic activities of purified His6P915L and His6eEF3 were measured. The pM Pi released from [-
32P]ATP are
shown after subtracting the hydrolysis in the presence of buffer alone. The results are an average of three
experiments and the S.D. shown. D, yeast extracts were prepared from strains containing eEF3 (TKY597),
His6eEF3 (TKY702), and His6P915L (TKY819), and equal amounts of total protein were incubated with
Ni2-NTA beads. Extract (E, 5%), supernatant (S, 5%), and pellet (P, 100%)were separated by SDS-PAGE and
analyzed by Western blot. The blot was probed with both anti-eEF3 and anti-eEF1A antibodies. E, eEF1A,
His6eEF3, andHis6P915LeEF3 proteinswere purified and ran on a SDS-PAGEgel and stainedwithGelCode Blue
(Pierce). F, a 5-foldmolar excess of purified eEF1A, either alone orwith purified His6eEF3 or His6P915L proteins,
were incubated with Ni2-NTA beads. Supernatant (S, 5%) and pellet (P, 100%) were separated by SDS-PAGE
and analyzed by Western blot with an anti-eEF1A antibody.
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confirms the prediction that eEF3 remains a monomer under
multiple conditions, including in the presence of ATP or ADP.
The binding of eEF3 to eEF1A occurs via amino acids 775–
980 that can be separated into 775–910 and 910–980, the latter
determined by analysis of the minimal overlapping binding
sites in a series of truncation. An important determinant in the
extent of the interaction of the two proteins is the nucleotide
bound state of eEF3. The ATPase inactive eEF3 mutants F650S
(16) and P915L (present study) are in different regions of the
protein but have a similar effect on eEF1Abinding. The F650S is
in the region between the two ATP binding domains. The
P915Lmutant is in one of the eEF1A binding regions. Both lose
the ability to interact with eEF1A, pointing toward hydrolysis of
ATP as a critical event in eEF1A binding. Consistent with these
findings, the presence of ADP stimulates eEF1A binding. This
shows that a sequential order of events likely occurs during the
steps catalyzed by eEF3.
EF-Tu, the bacterial homolog of eEF1A, has been shown to
bind aa-tRNA predominantly via residues in domain II,
whereas domain I contains the consensus GTP binding motif
(46, 47). Domain III of eEF1A is responsible for the overexpres-
sion phenotype of actin cytoskeletal disorganization (26). This
effect is lost for mutants located in domain III (26). This work
shows that domain III (333–458) of eEF1A has another func-
tion, the interaction with eEF3. This is also consistent with the
finding that neither GDP nor GTP affects eEF3 binding. Over-
expression of eEF3 results in enhanced growth at all tempera-
tures (16). This could be a result of its enhanced interaction
with either eEF1A and/or ribosomes driving translation elon-
gation forward, and hence, total translation is increased (16). If
eEF3 competes with actin to bind eEF1A via domain III, then
the increase in eEF3 may shift the balance of the cellular
machinery in favor of protein synthesis rather than toward the
function of eEF1A in cytoskeletal arrangements. This dynamic
cross-talk between the two cellular processes of protein synthe-
sis and cytoskeletal arrangement is likely mediated by the elon-
gation factor eEF1A andmay also be affected by the interaction
of eEF3 versus actin with eEF1A.
This study supports the model that the ATP hydrolysis by
eEF3 stimulates the interaction with eEF1A. This observation
fits in nicely with the model of eEF3 function, where ribosome-
stimulated nucleotide hydrolysis of the ATP-bound eEF3 pre-
cedes its interaction with eEF1A and the delivery of only cog-
nate aa-tRNA at the A-site. It is still speculative if eEF1A
binding occurs, whereas eEF3 is bound to or upon its release
from the ribosome. The latter situation is more likely since
uponATPhydrolysis, eEF3 is likely released from the ribosome.
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